Evidence map›Paper›PMID 38077442›Full record

ArticlePeerJ2023

Dark kinase annotation, mining, and visualization using the Protein Kinase Ontology.

Saber Soleymani, Nathan Gravel, Liang-Chin Huang, Wayland Yeung, Elika Bozorgi, Nathaniel G Bendzunas, Krzysztof J Kochut, Natarajan Kannan

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Saber SoleymaniDepartment of Computer Science, University of Georgia, Athens, GA, United States.
Nathan GravelInstitute of Bioinformatics, University of Georgia, Athens, GA, United States.
Liang-Chin HuangInstitute of Bioinformatics, University of Georgia, Athens, GA, United States.
Wayland YeungInstitute of Bioinformatics, University of Georgia, Athens, GA, United States.
Elika BozorgiDepartment of Computer Science, University of Georgia, Athens, GA, United States.
Nathaniel G BendzunasDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA, United States.
Krzysztof J KochutDepartment of Computer Science, University of Georgia, Athens, GA, United States.
Natarajan KannanInstitute of Bioinformatics, University of Georgia, Athens, GA, United States.
University of Georgia · US

Funding

Unlocking sequence-structure-function-disease relationships in large protein super-familiesR35GM139656 · NIGMS · UNIVERSITY OF GEORGIA · PI KANNAN, NATARAJAN · 2021 to 2025
$2.2M
A data analytics framework for mining the dark kinomeU01CA239106 · NCI · UNIVERSITY OF GEORGIA · PI KANNAN, NATARAJAN, KOCHUT, KRZYSZTOF J · 2019 to 2021
$1.3M
NCI NIH HHS U01 CA239106NIGMS NIH HHS R35 GM139656
6 · The paper itself

Abstract

The Protein Kinase Ontology (ProKinO) is an integrated knowledge graph that conceptualizes the complex relationships among protein kinase sequence, structure, function, and disease in a human and machine-readable format. In this study, we have significantly expanded ProKinO by incorporating additional data on expression patterns and drug interactions. Furthermore, we have developed a completely new browser from the ground up to render the knowledge graph visible and interactive on the web. We have enriched ProKinO with new classes and relationships that capture information on kinase ligand binding sites, expression patterns, and functional features. These additions extend ProKinO's capabilities as a discovery tool, enabling it to uncover novel insights about understudied members of the protein kinase family. We next demonstrate the application of ProKinO. Specifically, through graph mining and aggregate SPARQL queries, we identify the p21-activated protein kinase 5 (PAK5) as one of the most frequently mutated dark kinases in human cancers with abnormal expression in multiple cancers, including a previously unappreciated role in acute myeloid leukemia. We have identified recurrent oncogenic mutations in the PAK5 activation loop predicted to alter substrate binding and phosphorylation. Additionally, we have identified common ligand/drug binding residues in PAK family kinases, underscoring ProKinO's potential application in drug discovery. The updated ontology browser and the addition of a web component, ProtVista, which enables interactive mining of kinase sequence annotations in 3D structures and Alphafold models, provide a valuable resource for the signaling community. The updated ProKinO database is accessible at https://prokino.uga.edu.

Indexed as

NeoplasmsProtein KinasesHumansLigandsPhosphorylationProteinsLigandsProtein KinasesProteinsCancer genomesCell signalingCurationDrug discoveryNetwork biologyProtein functionProtein structureUser interface

Identifiers

PMID38077442
PMCPMC10704995
OpenAlexW4389340627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.